A Pilot Study of the Neural Correlates of Treatment Effect on Nicotine Craving
| Status: | Recruiting |
|---|---|
| Conditions: | Smoking Cessation, Tobacco Consumers |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - 55 |
| Updated: | 5/5/2014 |
| Contact: | Karen Drexler, MD |
| Email: | karen.drexler@med.va.gov |
| Phone: | 404-321-6111 |
Nicotine Craving: Neural Correlates of Treatment Effect - A Pilot Study
The purpose of this study is to gather pilot data to determine feasibility of and guide the
development of a larger clinical trial investigating the effects of topiramate as an adjunct
to nicotine replacement therapy and behavioral counseling in smoking cessation treatment.
It is hypothesized that topiramate will decrease nicotine craving and result in improved
outcomes for smoking cessation.
development of a larger clinical trial investigating the effects of topiramate as an adjunct
to nicotine replacement therapy and behavioral counseling in smoking cessation treatment.
It is hypothesized that topiramate will decrease nicotine craving and result in improved
outcomes for smoking cessation.
Inclusion Criteria:
- Male, between ages of 18-55
- Meets DSM-IV criteria for nicotine dependence
- Smoke at least 20 cigarettes per day
- Motivated to quit smoking
Exclusion Criteria:
- Serious or unstable medical conditions
- Current psychiatric disorder requiring medication or treatment
- Taking medication that create risk of interaction with study drug
- Current participation in another smoking cessation treatment
We found this trial at
1
site
Click here to add this to my saved trials
